Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 12571612)

Published in J Hum Hypertens on January 01, 2003

Authors

S Bianchi1, R Bigazzi, A Amoroso, V M Campese

Author Affiliations

1: Unita' Operativa di Nefrologia, Spedali Riuniti, Livorno, Italy.

Articles by these authors

Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med (1992) 2.69

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int (2006) 2.31

IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet (2000) 2.12

Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci U S A (1990) 1.54

Anti-cardiolipin antibodies in autoimmune thyroid diseases. Clin Endocrinol (Oxf) (1994) 1.53

Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients. Am J Hypertens (1992) 1.45

Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS. Am J Nephrol (1996) 1.44

Molecular analysis of uromodulin and SAH genes, positional candidates for autosomal dominant medullary cystic kidney disease linked to 16p12. J Nephrol (2001) 1.43

Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis. Nephrol Dial Transplant (1989) 1.42

Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens (1996) 1.38

Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proc Natl Acad Sci U S A (2003) 1.38

Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. Am J Kidney Dis (1999) 1.35

Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol (1997) 1.35

Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur J Immunol (1994) 1.32

The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur J Immunol (1993) 1.27

Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr Pharm Des (2002) 1.24

Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension (1991) 1.23

Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci U S A (1996) 1.23

Acute renal failure during intermittent rifampicin therapy. Nephron (1973) 1.19

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens (1998) 1.19

Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int (1982) 1.15

Flexibility of melting temperature assay for rapid detection of insertions, deletions, and single-point mutations of the AGXT gene responsible for type 1 primary hyperoxaluria. Clin Chem (2000) 1.15

Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol (1983) 1.13

A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens (1998) 1.13

Situational analysis of varying models of adherence support and loss to follow up rates; findings from 27 treatment facilities in eight resource limited countries. Trop Med Int Health (2010) 1.12

Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int (1981) 1.11

Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens (1994) 1.10

Bilateral renal cortical necrosis in two patients with Neisseria meningitidis sepsis. Am J Nephrol (1991) 1.10

Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int (1997) 1.07

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension (1994) 1.07

Familial clustering of IgA nephropathy: further evidence in an Italian population. Am J Kidney Dis (1999) 1.06

Unilateral breast enlargement secondary to hemodialysis arteriovenous fistula and subclavian vein occlusion. Nephron (1993) 1.05

Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol (1990) 1.03

Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas (2005) 1.03

Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int J Immunogenet (2006) 1.02

Identification of a new locus for medullary cystic disease, on chromosome 16p12. Am J Hum Genet (1999) 1.02

The penicillin resistance of Enterococcus faecalis JH2-2r results from an overproduction of the low-affinity penicillin-binding protein PBP4 and does not involve a psr-like gene. Microbiology (2001) 1.01

Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens (1995) 0.99

Patterning the ascidian nervous system: structure, expression and transgenic analysis of the CiHox3 gene. Development (1999) 0.97

Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). Int J Mol Med (2009) 0.97

Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metab (1979) 0.96

Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol (2006) 0.95

MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma. J Viral Hepat (2008) 0.94

A reliable screening procedure for coeliac disease in clinical practice. Scand J Gastroenterol (2002) 0.94

Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Lupus (2009) 0.93

Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes Immun (2000) 0.91

Cytokines expression in SLE nephritis. Eur Rev Med Pharmacol Sci (2011) 0.91

Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin. Am J Hypertens (1996) 0.91

Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF). J Clin Invest (1997) 0.90

ALS with variable phenotypes in a six-generation family caused by leu144phe mutation in the SOD1 gene. J Neurol Sci (2001) 0.90

Association between hyperlipidemia and microalbuminuria in essential hypertension. Kidney Int Suppl (1999) 0.89

Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases. Kidney Int (2006) 0.88

Long-term effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: a 1-year follow-up. Am J Nephrol (1991) 0.88

Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin Exp Immunol (1997) 0.88

Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am J Physiol Heart Circ Physiol (2000) 0.87

Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension (1996) 0.87

Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study. Clin Exp Rheumatol (1986) 0.87

Genetic and population structure of four Sardinian villages. Ann Hum Genet (1985) 0.87

The distribution of HLA antigens in Italy. Gene Geogr (1991) 0.86

Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron (1992) 0.86

Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients. Int J Cancer (1995) 0.86

Rapid method for detection of extra (TA) in the promoter of the bilirubin-UDP-glucuronosyl transferase 1 gene associated with Gilbert syndrome. Clin Chem (2000) 0.86

Apoptotic molecular mechanisms implicated in autoimmune diseases. Eur Rev Med Pharmacol Sci (2009) 0.85

Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts. Mod Pathol (1993) 0.85

Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use. J Autoimmun (1994) 0.84

Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. Nephrol Dial Transplant (1992) 0.84

Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12-mo follow-up of an Italian population. Diabetes (1987) 0.84

Human beta defensin 1 gene: six new variants. Hum Mutat (2000) 0.84

Social "status" and biological "status": a comparison of grave goods and skeletal indicators from Pontecagnano. Am J Phys Anthropol (2001) 0.84

Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension (1994) 0.83

Single-tube genotyping of MBL-2 polymorphisms using melting temperature analysis. Clin Exp Med (2002) 0.83

Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study. Climacteric (2005) 0.83

Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann Rheum Dis (1993) 0.83

Cytolitic activity of monoclonal antibodies strongly depends on rabbit complement used. Tissue Antigens (1981) 0.83

Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1. Hepatology (2001) 0.83

Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia. Clin Exp Immunol (1996) 0.83

Autosomal dominant medullary cystic disease: a disorder with variable clinical pictures and exclusion of linkage with the NPH1 locus. Nephrol Dial Transplant (1998) 0.82

The role of ribavirin in the combination therapy of hepatitis C virus infection. Curr Pharm Des (2004) 0.82

Genomic organization and chromosome mapping of the human homeobox gene HHEX. Cytogenet Cell Genet (2001) 0.82

Indication of a deeply bound and compact K- pp state formed in the pp- -> pLambdaK+ reaction at 2.85 GeV. Phys Rev Lett (2010) 0.82

Enhanced glucose tolerance in spontaneously hypertensive rats. Pancreatic beta-cell hyperfunction with normal insulin sensitivity. Diabetes (1992) 0.82

Interleukin-4RA gene polymorphism is associated with oral mucous membrane pemphigoid. Oral Dis (2013) 0.81

Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association? Ann Rheum Dis (2003) 0.81

Tuberculosis of the spine (Pott's disease) in patients with end-stage renal disease. Am J Nephrol (1994) 0.81

Modifications of the immune responsiveness in patients with hepatitis C virus infection following treatment with IFN-alpha/ribavirin. Curr Pharm Des (2002) 0.81

Severe life-threatening Ehrlichia chaffeensis infections transmitted through solid organ transplantation. Transpl Infect Dis (2013) 0.81

Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension. J Nephrol (1998) 0.81

Hypertension without peripheral insulin resistance in spontaneously hypertensive rats. Am J Physiol (1992) 0.81

Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection. Mol Med (2000) 0.81

The primary hyperoxalurias. Contrib Nephrol (2001) 0.81

Long-term treatment of systemic lupus erythematosus with cyclosporin A. Arthritis Rheum (1997) 0.81

Inferior vena cava duplication with reference to venous asymmetries. Ital J Anat Embryol (2002) 0.81

Antibodies to carbonic anhydrase in patients with connective tissue diseases: relationship with lung involvement. Int J Immunopathol Pharmacol (2008) 0.80

Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features. Panminerva Med (2009) 0.80